Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort.
Lavender B, Hooker C, Frampton C, Williams M, Carson S, Paterson A, McGregor R, Moreland NJ, Gell K, Priddy FH, Wiig K, Le Gros G, Ussher JE, Brewerton M.
Lavender B, et al. Among authors: wiig k.
Vaccine. 2023 Aug 31;41(38):5535-5544. doi: 10.1016/j.vaccine.2023.07.051. Epub 2023 Jul 27.
Vaccine. 2023.
PMID: 37516574
Free article.